| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
F-box and WD repeat domain containing 7 | 0.465 | 0.808 | 1.00 |
|
group | 0.420 | None | 0.667 | 1 | 0 | 2008 | 2016 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
progestagen associated endometrial protein | 0.430 | 0.846 | 3.1E-08 |
|
group | 0.390 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
group | 0.380 | None | 1.000 | 1 | 0 | 2003 | 2018 | ||||||||
|
estrogen related receptor alpha | 0.548 | 0.654 | 0.60 |
|
group | 0.370 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
group | 0.370 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
N-myc downstream regulated 1 | 0.488 | 0.731 | 1.1E-02 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2005 | 2013 | ||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2009 | 2019 | |||||||||
|
microRNA 206 | 0.477 | 0.846 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2008 | 2017 | |||||||||
|
microRNA 221 | 0.449 | 0.846 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2008 | 2016 | |||||||||
|
Yes associated protein 1 | 0.432 | 0.808 | 1.00 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
anterior gradient 2, protein disulphide isomerase family member | 0.556 | 0.692 | 9.2E-08 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
fms related receptor tyrosine kinase 1 | 0.419 | 0.846 | 1.00 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2002 | 2015 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
microRNA 10b | 0.509 | 0.808 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2007 | 2019 | |||||||||
|
Y-box binding protein 1 | 0.519 | 0.769 | 0.95 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2005 | 2014 | ||||||||
|
thrombospondin 1 | 0.407 | 0.885 | 1.00 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 1997 | 2017 | ||||||||
|
nuclear receptor coactivator 1 | 0.563 | 0.731 | 1.00 |
|
group | 0.340 | None | 0.800 | 1 | 0 | 2001 | 2015 | ||||||||
|
fibroblast growth factor 4 | 0.588 | 0.577 | 0.14 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 1996 | 2011 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
H19 imprinted maternally expressed transcript | 0.494 | 0.923 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 1996 | 2017 | |||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2003 | 2018 | ||||||||
|
breast cancer anti-estrogen resistance 4 | 0.653 | 0.346 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2006 | 2011 |